Compare BZFDW & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BZFDW | GRML |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 611 | N/A |
| Industry | Movies/Entertainment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2021 | 2022 |
| Metric | BZFDW | GRML |
|---|---|---|
| Price | $0.02 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.7K | ★ 1.6M |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $0.33 |
| 52 Week High | $0.14 | $0.44 |
| Indicator | BZFDW | GRML |
|---|---|---|
| Relative Strength Index (RSI) | 43.88 | 52.11 |
| Support Level | $0.01 | $0.33 |
| Resistance Level | $0.03 | $0.44 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 28.57 | 53.81 |
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
Greenland Mines Ltd operates in two divisions: (1) Natural Resources, focused on the exploration and development of the Skaergaard Project in Southeast Greenland, an undeveloped palladium, gold, and platinum deposit; and 2) Cell and Gene Therapy, which focuses on the development of biologic, cell, and gene therapies for neurodegenerative and age-related disorders, including Alzheimer's, amyotrophic lateral sclerosis (ALS), Parkinson's, and related conditions, targeting areas of high unmet medical need.